Hetero Drugs Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Hetero Drugs Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3477
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hetero Drugs Ltd (Hetero) is a manufacturer of active pharmaceutical ingredients, intermediate chemicals and finished dosages. The company specializes in process chemistry, API manufacturing, formulation development, manufacturing and commercialization of bio-generics, and also offers custom research and manufacturing services to global biotechnology and pharmaceutical companies. Hetero offers products in various therapeutic areas which include HIV/AIDS, oncology, cardiovascular, neurology and hepatitis, among others. The company conducts research and development to develop new products. It markets its products through a network of marketing offices across the world. Hetero is headquartered in Hyderabad, Telangana, India.

Hetero Drugs Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hetero Drugs Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Oasmia Pharma Enters into Marketing and Distribution Agreement with Hetero Drugs 11
Kadmon Amends Supply And Distribution Agreement with Camber Pharma 12
Stada Arzneimittel to Form Joint Venture with Hetero Drugs 13
Cipla Enters into Co-Marketing Agreement with Hetero Drugs 14
Furen Pharma to Form JV with Hetero Drugs for Oncology and AIDS 15
DFH Pharma Enters Into R&D Agreement With Hetero For HIV Drugs 16
Hetero Drugs Forms Joint Venture With Neopharma 17
Licensing Agreements 18
Hetero Enters into Licensing Agreement with VIVUS for STENDRA 18
Aurobindo Pharma, Cipla, Desano Pharma, Emcure Pharma, Hetero Labs and Laurus Labs Enter into Licensing Agreement with Medicines Patent Pool 19
Hetero Labs Enters into Licensing Agreement with Medicines Patent Pool 20
Hetero Labs Enters into Licensing Agreement with Medicines Patent Pool 21
Cipla, Emcure Pharma, Hetero Drugs, Natco Pharma and Aurobindo Pharma Enter into Licensing Agreement with Medicines Patent Pool and Bristol-Myers Squibb 22
Dr Reddy’s Labs Enters into Licensing Agreement with Hetero Drugs for Sofosbuvir 24
Gilead Sciences Enters into Licensing Agreement with Hetero Labs 25
Hetero Drugs Ltd – Key Competitors 26
Hetero Drugs Ltd – Key Employees 27
Hetero Drugs Ltd – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Joint Venture 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hetero Drugs Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hetero Drugs Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Oasmia Pharma Enters into Marketing and Distribution Agreement with Hetero Drugs 11
Kadmon Amends Supply And Distribution Agreement with Camber Pharma 12
Stada Arzneimittel to Form Joint Venture with Hetero Drugs 13
Cipla Enters into Co-Marketing Agreement with Hetero Drugs 14
Furen Pharma to Form JV with Hetero Drugs for Oncology and AIDS 15
DFH Pharma Enters Into R&D Agreement With Hetero For HIV Drugs 16
Hetero Drugs Forms Joint Venture With Neopharma 17
Hetero Enters into Licensing Agreement with VIVUS for STENDRA 18
Aurobindo Pharma, Cipla, Desano Pharma, Emcure Pharma, Hetero Labs and Laurus Labs Enter into Licensing Agreement with Medicines Patent Pool 19
Hetero Labs Enters into Licensing Agreement with Medicines Patent Pool 20
Hetero Labs Enters into Licensing Agreement with Medicines Patent Pool 21
Cipla, Emcure Pharma, Hetero Drugs, Natco Pharma and Aurobindo Pharma Enter into Licensing Agreement with Medicines Patent Pool and Bristol-Myers Squibb 22
Dr Reddy's Labs Enters into Licensing Agreement with Hetero Drugs for Sofosbuvir 24
Gilead Sciences Enters into Licensing Agreement with Hetero Labs 25
Hetero Drugs Ltd, Key Competitors 26
Hetero Drugs Ltd, Key Employees 27
Hetero Drugs Ltd, Other Locations 28
Hetero Drugs Ltd, Subsidiaries 28
Hetero Drugs Ltd, Joint Venture 29

List of Figures
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Hetero Drugs Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • I-Sens Inc (099190):企業の製品パイプライン分析2018
    Summary I-Sens Inc (I-SENS) is a medical device company that develops and distributes blood glucose monitoring systems. The company’s products comprise electrolyte and gas analyzers, blood glucose monitoring systems, immuno sensors and accessories, among others. It provides its blood monitoring syst …
  • British Business Bank Plc:企業の戦略的SWOT分析
    British Business Bank Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Romelectro S.A.:企業の戦略的SWOT分析
    Romelectro S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Zain Group:企業の戦略・SWOT・財務情報
    Zain Group - Strategy, SWOT and Corporate Finance Report Summary Zain Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Coro Mining Corp:企業の戦略・SWOT・財務情報
    Coro Mining Corp - Strategy, SWOT and Corporate Finance Report Summary Coro Mining Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Diploma PLC (DPLM):企業の財務・戦略的SWOT分析
    Summary Diploma PLC (Diploma) is a supplier of technical products and services. The company operates through its business such as life sciences, seals and controls. Its life sciences segment supplies instrumentation, consumables, and related services to the healthcare and environmental industries. D …
  • Hyundai Motor Company:企業の戦略・SWOT・財務分析
    Hyundai Motor Company - Strategy, SWOT and Corporate Finance Report Summary Hyundai Motor Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Kyowa Hakko Kirin Co., Ltd.:企業のM&A・事業提携・投資動向
    Kyowa Hakko Kirin Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kyowa Hakko Kirin Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • IntriCon Corp (IIN):企業の財務・戦略的SWOT分析
    Summary IntriCon Corp (IntriCon) is a designer, developer and manufacturer of miniature and micro-miniature body-worn medical and electronics products. The company’s products comprise glucose monitoring, medical coils, cardiac monitoring, amplifiers, systems, plastic medical molding, support product …
  • Kleo Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kleo Pharmaceuticals Inc (Kleo Pharmaceuticals) is a biotechnology company that develops small molecules in the field of immunotherapy to emulate biologics. The company provides adaptable technology platforms such as antibody recruiting molecules (ARMs) and synthetic antibody mimics (SyAMs) …
  • US Foods Holding Corp. (USFD):企業の財務・戦略的SWOT分析
    US Foods Holding Corp. (USFD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Bankers Insurance Group:企業の戦略・SWOT・財務情報
    Bankers Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Bankers Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ellex Medical Lasers Limited (ELX):企業の財務・戦略的SWOT分析
    Ellex Medical Lasers Limited (ELX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Eisai Inc-製薬・医療分野:企業M&A・提携分析
    Summary Eisai Inc (Eisai) is a healthcare company, which focuses on the discovery, development and marketing of pharmaceutical products. The company's major products include Aricept for Alzheimer’s treatment, Aciphex for acid reflux, Akynzeo for nausea and vomiting dring the course of cancer chemoth …
  • Companhia Energetica de Sao Paulo (CESP6):企業の財務・戦略的SWOT分析
    Companhia Energetica de Sao Paulo (CESP6) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Cracker Barrel Old Country Store, Inc. (CBRL):企業の財務・戦略的SWOT分析
    Cracker Barrel Old Country Store, Inc. (CBRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Printpack Inc:企業の戦略的SWOT分析
    Printpack Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Gainesville Regional Utilities:企業の戦略的SWOT分析
    Gainesville Regional Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • SI-Bone Inc:医療機器:M&Aディール及び事業提携情報
    Summary SI-Bone Inc (SI-BONE) is a medical device company that develops, manufactures and distributes diagnosing and treating patients with SI joint disorders products and tools. The company offers medical devices for patients with low back issues, degenerative sacroiliitis, and SI joint disruptions …
  • Mega Corporation Ltd:企業の戦略・SWOT・財務分析
    Mega Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Mega Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆